NFKB1 and cancer: Our previous data on the same tumor cellular models, demonstrated that the redox perturbation due to natural compounds led to inhibition of NF-κB, a transcriptional factor often constitutively activated in many type of cancers and an important target for antitumor therapy [11, 27].